Quantcast

Latest epilepsy Stories

2014-05-05 12:29:04

In the news release, U.S. Market for Neurostimulation Devices Will Reach Almost $4 Billion by 2022, issued 09-Apr-2014 by Decision Resources Group over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read "NeuroPace's responsive stimulation device" rather than "NeuroPace's deep brain stimulation (DBS) device" as originally issued. The complete, corrected release follows: U.S. Market for Neurostimulation Devices Will Reach Almost $4 Billion by...

2014-05-05 08:29:03

Companies and Researchers to Showcase Innovation in the Treatment of Seizures Family Education Day Registration on June 7th Has Reached Capacity LANDOVER, Md., May 5, 2014 /PRNewswire-USNewswire/ -- The Epilepsy Foundation announced today that the 4(th )Biennial Epilepsy Pipeline Conference 2014, an initiative of the Epilepsy Therapy Project, will feature a stellar line up of therapeutic and medical device developers, clinical investigators and industry leaders presenting the latest...

2014-04-30 23:16:18

A&A Packaging comments on a Canadian mother’s story of how medical marijuana saved her once terminally ill daughter's life, and cured her from having 100 seizures a day. Seattle, WA (PRWEB) April 30, 2014 Only until recently has medical marijuana received its deserved accolades by the mainstream media as a miracle drug; however, many in the medical industry are still leaving pot on the back-burner....until NOW. A Canadian mother named Sarah Wilkinson has tangible claims about...

2014-04-30 08:32:32

ATLANTA, April 30, 2014 /PRNewswire/ -- Today, the U.S. Department of Veterans Affairs' Epilepsy Centers of Excellence (ECoE), biopharmaceutical company UCB, and health data sharing network PatientsLikeMe(®) presented the results of the Policy for Optimal Epilepsy Management (POEM) study at the 66(th) Annual Meeting of the American Academy of Neurology in Philadelphia, Pa. This first-time, real-world study of an online health management platform demonstrated statistically significant...

2014-04-29 16:59:13

A graduate student in Semel Institute for Neuroscience and Human Behavior, and two of his undergraduate trainees, were selected by the Council on Undergraduate Research to present their original research on Capitol Hill in Washington, D.C., on Tuesday. Wesley Kerr, whose graduate studies will be completed in the UCLA Department of Biomathematics, and his trainees, Akash Patel and Sarah Barritt, will present their poster entitled "Computer-Aided Diagnosis of Epilepsy Using Clinical...

2014-04-29 16:31:05

USL261 Demonstrates Promising PK, PD and Safety Profiles in Patients with Epilepsy PHILADELPHIA, April 29, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (investigational intranasal midazolam) in patients with epilepsy were presented at the 66(th)( )Annual American Academy of Neurology (AAN) meeting in Philadelphia. The results demonstrated that USL261 at a single dose of up to 7.5 mg was rapidly absorbed and exhibited a...

2014-04-28 16:27:09

PHILADELPHIA, April 28, 2014 /PRNewswire-USNewswire/ -- A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease. Not enough evidence was found to show if medical marijuana is helpful in treating motor problems in...

2014-04-28 08:32:57

HOUSTON, April 28, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced the promotion of Rohan Hoare, Ph.D., to the newly created role of Chief Operating Officer. As COO, Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O'Neill F. D'Cruz, M.D. recently joined the company as Chief Medical Officer. "We have made significant, multi-year investments in our sales...

2014-04-25 08:27:40

WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc. announced today that six abstracts highlighting data analyses for FYCOMPA(TM) (perampanel) will be presented at the 66(th) annual American Academy of Neurology (AAN) meeting, taking place in Philadelphia, PA from April 26( )- May 3. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO "Eisai and its epilepsy franchise are committed to expanding its knowledge of current products and developing new medications for the...

2014-04-23 12:30:45

Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsy MADISON, N.J., April 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neurology business designed to help physicians more reliably and quickly diagnose the...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related